Detection of NDM-1/5 and OXA-48 Co-producing Extensively Drug-resistant Hypervirulent Klebsiella Pneumoniae in Northern Italy
Overview
Authors
Affiliations
Objectives: Using a hybrid long-read sequencing approach, we aimed to fully characterise four extensively-drug resistant (XDR) hypervirulent Klebsiella pneumoniae isolates, one of which represented the first strain isolated in Italy co-expressing NDM-1/5 and OXA-48 carbapenemases.
Methods: Whole-genome sequencing was performed using Illumina and Oxford Nanopore Technology platforms. An assembly pipeline was used to recover the structures both of the chromosome and plasmids.
Results: Multilocus sequence typing (MLST) showed that these strains belonged to high-risk sequence types (STs) not commonly circulating in Italy (ST383, ST147 and ST15). The hybrid sequencing approach allowed to characterise three multidrug resistance plasmids, which demonstrated high homology with previously sequenced plasmids, that were simultaneously detected in one ST383 strain carrying, respectively, bla, bla and bla.
Conclusion: This is the first report in Italy of new hypervirulent XDR K. pneumoniae clones characterised by co-production of OXA-48, NDM-1 and NDM-5. The discovery of new high-risk clones harbouring multiple mobile elements is a growing problem that poses a great challenge for public health.
Circulation of a Unique Clone, ST147 NDM-1/OXA-48, in Two Diverse Hospitals in Calabria (Italy).
Nicitra E, Terrana M, Bongiorno D, Dodaro S, Greco F, Greco S Antibiotics (Basel). 2025; 14(2).
PMID: 40001372 PMC: 11851497. DOI: 10.3390/antibiotics14020128.
Hypervirulent (hv): Overview, Epidemiology, and Laboratory Detection.
Al Ismail D, Campos-Madueno E, Dona V, Endimiani A Pathog Immun. 2025; 10(1):80-119.
PMID: 39911145 PMC: 11792540. DOI: 10.20411/pai.v10i1.777.
Rotondo C, Venditti C, Butera O, Dimartino V, Messina F, Properzi M Antibiotics (Basel). 2024; 13(11).
PMID: 39596739 PMC: 11590914. DOI: 10.3390/antibiotics13111045.
Contributions of Long-Read Sequencing for the Detection of Antimicrobial Resistance.
Sierra R, Roch M, Moraz M, Prados J, Vuilleumier N, Emonet S Pathogens. 2024; 13(9).
PMID: 39338921 PMC: 11434816. DOI: 10.3390/pathogens13090730.
Sobh G, Araj G, Finianos M, Sourenian T, Hrabak J, Pappagianitsis C Front Cell Infect Microbiol. 2024; 14:1407246.
PMID: 38962322 PMC: 11219574. DOI: 10.3389/fcimb.2024.1407246.